Free Trial

Check-Cap (CHEK) Competitors

Check-Cap logo
$0.68 -0.06 (-8.47%)
Closing price 08/1/2025 03:58 PM Eastern
Extended Trading
$0.68 +0.00 (+0.71%)
As of 08/1/2025 07:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CHEK vs. DRCT, SLGL, IINN, INBS, MHUA, XAIR, BTCY, DHAI, WOK, and LYRA

Should you be buying Check-Cap stock or one of its competitors? The main competitors of Check-Cap include Direct Digital (DRCT), Sol-Gel Technologies (SLGL), Inspira Technologies OXY B.H.N. (IINN), Intelligent Bio Solutions (INBS), Meihua International Medical Technologies (MHUA), Beyond Air (XAIR), Biotricity (BTCY), DIH Holding US (DHAI), WORK Medical Technology Group (WOK), and Lyra Therapeutics (LYRA).

Check-Cap vs. Its Competitors

Direct Digital (NASDAQ:DRCT) and Check-Cap (NASDAQ:CHEK) are related small-cap companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability.

In the previous week, Direct Digital had 3 more articles in the media than Check-Cap. MarketBeat recorded 3 mentions for Direct Digital and 0 mentions for Check-Cap. Check-Cap's average media sentiment score of 0.00 beat Direct Digital's score of -1.00 indicating that Check-Cap is being referred to more favorably in the news media.

Company Overall Sentiment
Direct Digital Negative
Check-Cap Neutral

Direct Digital has a beta of 6.07, indicating that its share price is 507% more volatile than the S&P 500. Comparatively, Check-Cap has a beta of 0.19, indicating that its share price is 81% less volatile than the S&P 500.

Direct Digital has higher revenue and earnings than Check-Cap. Direct Digital is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Direct Digital$48.17M0.20-$6.24M-$1.76-0.29
Check-CapN/AN/A-$17.57M-$3.00-0.23

Check-Cap has a net margin of 0.00% compared to Direct Digital's net margin of -16.23%.

Company Net Margins Return on Equity Return on Assets
Direct Digital-16.23% N/A -24.12%
Check-Cap N/A N/A N/A

Direct Digital currently has a consensus price target of $6.00, indicating a potential upside of 1,092.61%. Given Direct Digital's stronger consensus rating and higher possible upside, equities analysts plainly believe Direct Digital is more favorable than Check-Cap.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Direct Digital
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Check-Cap
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

4.0% of Direct Digital shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 62.8% of Direct Digital shares are held by company insiders. Comparatively, 0.5% of Check-Cap shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Direct Digital beats Check-Cap on 10 of the 14 factors compared between the two stocks.

Get Check-Cap News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHEK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CHEK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHEK vs. The Competition

MetricCheck-CapMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$4.33M$6.76B$5.49B$9.52B
Dividend YieldN/A1.32%4.73%4.09%
P/E Ratio-0.2320.9428.7823.81
Price / SalesN/A54.12372.2066.04
Price / CashN/A20.5035.4557.96
Price / Book0.174.468.275.54
Net Income-$17.57M$174.54M$3.25B$259.28M
7 Day Performance-9.71%-5.27%-3.70%-4.64%
1 Month Performance-10.89%-3.94%4.34%4.41%
1 Year Performance-65.80%8.26%25.90%17.95%

Check-Cap Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CHEK
Check-Cap
N/A$0.68
-8.5%
N/A-66.1%$4.33MN/A-0.2380Gap Down
DRCT
Direct Digital
2.5605 of 5 stars
$0.52
-1.6%
$6.00
+1,043.3%
-86.8%$10.08M$62.29M-0.3060Negative News
Upcoming Earnings
SLGL
Sol-Gel Technologies
1.8078 of 5 stars
$8.42
+3.6%
$40.00
+375.1%
+209.5%$22.65M$11.54M-1.7950Gap Down
IINN
Inspira Technologies OXY B.H.N.
1.6573 of 5 stars
$1.30
-7.8%
$2.00
+53.8%
+10.8%$17.80MN/A0.0020
INBS
Intelligent Bio Solutions
0.5811 of 5 stars
$2.03
-5.6%
N/A+9.7%$14.86M$3.11M0.0010
MHUA
Meihua International Medical Technologies
1.4362 of 5 stars
$0.43
-4.0%
N/A-59.9%$14.35M$96.90M0.00620Positive News
Gap Up
XAIR
Beyond Air
3.8467 of 5 stars
$3.32
+1.8%
$23.67
+612.9%
-74.0%$14.08M$3.70M-0.2170Short Interest ↑
High Trading Volume
BTCY
Biotricity
N/A$0.48
+10.2%
N/A-40.4%$11.96M$12.06M-0.4440High Trading Volume
DHAI
DIH Holding US
0.8364 of 5 stars
$0.29
+18.8%
N/A-91.5%$11.74M$64.47M-0.98N/ANews Coverage
High Trading Volume
WOK
WORK Medical Technology Group
N/A$0.82
+4.1%
N/AN/A$11.48M$11.51M0.00226
LYRA
Lyra Therapeutics
3.018 of 5 stars
$8.15
+3.2%
$100.00
+1,127.0%
-57.0%$10.47M$1.53M-0.1350Positive News

Related Companies and Tools


This page (NASDAQ:CHEK) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners